Mary Kay Fenton
2022 - Tourmaline Bio
In 2022, Mary Kay Fenton earned a total compensation of $2.2M as Former Interim Chief Executive Officer and President and Chief Financial Officer at Tourmaline Bio.
Compensation breakdown
Non-Equity Incentive Plan | $131,783 |
---|---|
Option Awards | $1,301,440 |
Salary | $455,000 |
Stock Awards | $308,800 |
Other | $12,200 |
Total | $2,209,223 |
Fenton received $1.3M in option awards, accounting for 59% of the total pay in 2022.
Fenton also received $131.8K in non-equity incentive plan, $455K in salary, $308.8K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Mary Kay Fenton's compensation ranked 1,625th out of 5,753 executives tracked by ExecPay. In other words, Fenton earned more than 71.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,625 | 72nd |
Manufacturing | 837 | 73rd |
Chemicals And Allied Products | 330 | 77th |
Drugs | 306 | 77th |
Biological Products, Except Diagnostic Substances | 75 | 74th |
Fenton's colleagues
We found two more compensation records of executives who worked with Mary Kay Fenton at Tourmaline Bio in 2022.